These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7843648)

  • 21. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells.
    Herbert JM; Savi P; Jeske WP; Walenga JM
    Thromb Haemost; 1998 Aug; 80(2):326-31. PubMed ID: 9716161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
    Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
    Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    J Clin Invest; 1986 Apr; 77(4):1272-7. PubMed ID: 3007578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human platelet factor 4 and protamine sulphate interaction with glycosaminoglycans in the rabbit.
    Cella G; Myers CJ; Prosdocimi M; Sasahara AA
    Eur J Clin Invest; 1987 Dec; 17(6):548-54. PubMed ID: 3123254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
    Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
    Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of platelet factor 4 on the neutralization of heparin by protamine.
    Shanberge JN; Quattrociocchi-Longe TM
    Ann N Y Acad Sci; 1989; 556():354-65. PubMed ID: 2735664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood.
    Pengo V; Boschello M; Prandoni P; Schivazappa L; Girolami A
    Thromb Res; 1985 Sep; 39(5):645-50. PubMed ID: 2417360
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of platelets with standard heparin and low molecular weight fractions.
    Dunn FW; Soria C; Thomaidis A; Soria J; Dupuy E; Bellucci S; Tobelem G
    Nouv Rev Fr Hematol (1978); 1984; 26(4):249-53. PubMed ID: 6089103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An objective assessment of the interaction of heparin and its fractions with human platelets.
    Brace LD; Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):190-8. PubMed ID: 4035366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
    Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
    Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.
    Pearce AC; Wonerow P; Marshall SJ; Frampton J; Gartner TK; Watson SP
    Biochem J; 2004 Feb; 378(Pt 1):193-9. PubMed ID: 14558887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
    Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
    Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.
    Furman MI; Krueger LA; Linden MD; Barnard MR; Frelinger AL; Michelson AD
    J Am Coll Cardiol; 2004 Jun; 43(12):2319-25. PubMed ID: 15193700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulant effects of protamine sulfate in a canine model.
    Kresowik TF; Wakefield TW; Fessler RD; Stanley JC
    J Surg Res; 1988 Jul; 45(1):8-14. PubMed ID: 3392995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.